Non-commercial vs . commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee-Reference-Cited by-同舟云学术

Non-commercial vs . commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee

Published:2018-03-22 Issue:6 Volume:84 Page:1384-1388
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Fuentes Camps Inmaculada¹²^ORCID,Rodríguez Alexis¹²,Agustí Antonia¹³

Affiliation:

1. Clinical Pharmacology Service; Hospital Universitari Vall d'Hebron; Barcelona Spain

2. Vall d'Hebron Research Institute (VHIR); Barcelona Spain

3. Department of Pharmacology, Therapeutics and Toxicology; Universitat Autònoma de Barcelona; Cerdanyola del Vallès, Barcelona Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13555/fullpdf

Reference19 articles.

1. Fact or fiction: the need for independent pharmaceutical policy research;Keyhani;J Gen Intern Med,2009

2. The continued need for independent research on prescription drugs;Hoadley;Health Aff,2004

3. Independent clinical research in Europe;Remuzzi;Lancet,2004

4. Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries;Hartmann;Trials,2012

5. Directive 2001/20/EC of the European Parliament and the Council of 4 Apr 2001 on the approximation of laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use;Anon;Official J Eur Community,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Academic Clinical Trials Submitted to an Institutional Ethics Committee at a Tertiary Care Center: A Retrospective Analysis;Cureus;2024-02-02

2. “Nothing to lose and the possibility of gaining”: a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians;Trials;2023-02-07

3. Contracts and Budgets;Principles and Practice of Clinical Trials;2022

4. Comment on “The effect of mutation status, pathological features and tumor location on prognosis in patients with colorectal cancer”;Revista da Associação Médica Brasileira;2021-12

5. Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT);BMC Medical Research Methodology;2021-08-31